EKO / TSX
MONTREAL, March 22 /CNW Telbec/ - Noveko International Inc. ("the Company") is pleased to announce that its subsidiary Noveko Inc. ("Noveko") has entered into a distribution agreement with AMD-Ritmed Inc. ("AMD-Ritmed"), a North American leader in the development and distribution of specialized high-quality and disposable medical supplies. This agreement covers the sale and promotion of Microban(R) hand sanitizers, in Canada, in the health professionals market, including hospital, medical and veterinary settings, and in the United States, to specialized healthcare providers, all subject to certain exceptions. The agreement covers an initial period of two years.
"We are pleased to team up with AMD-Ritmed which, thanks to its many years of experience and extensive distribution network, has acquired an expertise and a leading position in the specialty medical supplies industry. This strategic agreement fits perfectly with our objective of expanding our client base for our Microban(R) hand sanitizers in the promising healthcare markets," indicated Mr. Alain Bolduc, President and Chief Operating Officer of the Company.
"Our agreement with Noveko enables us to provide all our clients with an even more complete line of hygienic and protective solutions. We believe that all those involved in the healthcare sector - employees, patients and visitors - are now well aware of the importance of maintaining healthy hand hygiene to reduce the risk of spreading diseases and will hence rapidly adopt this line of hand sanitizers," said Mr. Ian Levine, President of AMD-Ritmed.
AMD-Ritmed started up more than 30 years ago as a manufacturer of surgical dressings for the U.S. market. Since then, it has expanded its product offering and operations in medical markets through its sustained research and development efforts and with the support of its partners notably Pharmascience Inc. and A.R. Medicom Inc., an affiliate. AMD-Ritmed is now present in Canada, the United States, Europe and Asia.
Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, including air filters, surgical masks and respirators, along with other products with antibacterial properties such as Microban(R) brand hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to account for new information, new events or new circumstances.
SOURCE Noveko International Inc.
For further information: For further information: Chantal Vennat, Director, Investor Relations and Corporate Communications, Noveko International Inc., (514) 875-0606; http://www.noveko.com